Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy
- 20 June 2008
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 102 (12), 1471-1482
- https://doi.org/10.1161/CIRCRESAHA.108.175174
Abstract
Cell-based therapies for the prevention and treatment of cardiac dysfunction offer the potential to significantly modulate cardiac function and improve outcomes in patients with cardiovascular disease. To date several clinical studies have suggested the potential efficacy of several different stem cell types; however, the benefits seen in clinical trials have been inconsistent and modest. In parallel, preclinical studies have identified key events in the process of cell-based myocardial repair, including stem cell homing, engraftment, survival, paracrine factor release, and differentiation that need to be optimized to maximize cardiac repair and function. The inconsistent and modest benefits seen in clinical trials combined with the preclinical identification of mediators responsible for key events in cell-based cardiac repair offers the potential for cell-based therapy to advance to cell-based gene therapy in an attempt to optimize these key events in the hope of maximizing clinical benefit. Below we discuss potential key events in cardiac repair and the mediators of these events that could be of potential interest for genetic enhancement of stem cell–based cardiac repair.Keywords
This publication has 108 references indexed in Scilit:
- Periostin is essential for cardiac healingafter acute myocardial infarctionThe Journal of Experimental Medicine, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Genetic Manipulation of Periostin Expression Reveals a Role in Cardiac Hypertrophy and Ventricular RemodelingCirculation Research, 2007
- Mesenchymal Stem Cells Use Integrin β1 Not CXC Chemokine Receptor 4 for Myocardial Migration and EngraftmentMolecular Biology of the Cell, 2007
- Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regenerationJournal of Cell Science, 2007
- Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2007
- Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repairProceedings of the National Academy of Sciences of the United States of America, 2007
- Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3β signalingBiochemical and Biophysical Research Communications, 2007
- Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapyProceedings of the National Academy of Sciences of the United States of America, 2006
- Differential regulation of Tbx5 protein expression and sub-cellular localization during heart developmentDevelopmental Biology, 2006